Hillsdale Investment Management Inc. Vertex Pharmaceuticals Inc Transaction History

Hillsdale Investment Management Inc.

$1.13 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $160,024 - $182,551	-565 Reduced 28.97%	1,385 $436,000
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $11,430 - $12,859	40 Added 2.09%	1,950 $563,000
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $13,691 - $15,276	-50 Reduced 2.55%	1,910 $552,000
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $46,992 - $58,510	-200 Reduced 9.26%	1,960 $553,000
Q1 2022 Apr 28, 2022	BUY	$221.42 - $260.97 $11,071 - $13,048	50 Added 2.37%	2,160 $564,000
Q4 2021 Feb 07, 2022	BUY	$177.01 - $223.45 $6,195 - $7,820	35 Added 1.69%	2,110 $463,000
Q2 2021 Jul 29, 2021	BUY	$187.49 - $221.1 $11,249 - $13,266	60 Added 2.98%	2,075 $419,000
Q1 2021 Apr 22, 2021	BUY	$207.02 - $241.31 $10,351 - $12,065	50 Added 2.54%	2,015 $433,000
Q2 2020 Aug 11, 2020	SELL	$225.48 - $295.8 $107,103 - $140,505	-475 Reduced 19.47%	1,965 $570,000
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $43,344 - $58,216	-260 Reduced 9.63%	2,440 $535,000
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $16,623 - $18,709	-100 Reduced 3.57%	2,700 $458,000
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $58,942 - $70,092	360 Added 14.75%	2,800 $515,000
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $56,206 - $71,117	-370 Reduced 13.17%	2,440 $405,000
Q2 2018 Aug 13, 2018	SELL	$145.72 - $169.96 $1,457 - $1,699	-10 Reduced 0.35%	2,810 $477,000
Q1 2018 May 14, 2018	SELL	$151.6 - $177.13 $15,160 - $17,713	-100 Reduced 3.42%	2,820 $460,000
Q4 2017 Feb 13, 2018	BUY	$137.28 - $155.55 $13,728 - $15,555	100 Added 3.55%	2,920 $438,000
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $62,214 - $68,140	420 Added 17.5%	2,820 $429,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,400	2,400 $309,000

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.8 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.9 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$11 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$6.06 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.41 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Account